FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Research compound · compound · checked 2026-10-09
NMN (Nicotinamide Mononucleotide) is listed here as a compound. Nucleotide intermediate in NAD biosynthesis; NMN and NAD+ are distinct molecules. Status was checked 2026-10-09. This card reports cited facts. It does not tell you to use NMN (Nicotinamide Mononucleotide) or how much to take.
Last checked Oct 9, 2026 by PepBear. Not medical advice.
Other names in the library: nicotinamide mononucleotide, NMN Powder — 100g, NMN Powder — 10g, NMN Powder — 25g, NMN Powder — 50g, NMN. Evidence describes the named substance, not a quality certification or equivalence assessment of commercial stock. Listed sizes: no listed milligram sizes in the vendor file. A seller title is a listing. It does not prove the vial matches a paper.
Nucleotide intermediate in NAD biosynthesis; NMN and NAD+ are distinct molecules.
FDA product approval
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
Compounding
not established. Legal compounding eligibility is not established here. Sale or a supplement label does not establish eligibility.
Research
investigational. Postmenopausal women with prediabetes and overweight or obesity in a 10-week randomized trial.
Sport
unknown. Not individually verified against current sport rules. Check the exact ingredients with your sport authority.
We mark the cited papers as B for Postmenopausal women with prediabetes and overweight or obesity in a 10-week randomized trial. and The trial measured improved muscle insulin sensitivity.. This narrow metabolic result does not demonstrate lifespan extension or establish equivalence of other preparations. The trial measured improved muscle insulin sensitivity. This narrow metabolic result does not demonstrate lifespan extension or establish equivalence of other preparations. Risks on the record: Human safety for this exact preparation is incompletely characterized. A lack of reported problems does not establish safety.
We mark the cited papers as B. That is our label for how strong those papers are. It does not say the compound works.
human-trial
The trial measured improved muscle insulin sensitivity.
Postmenopausal women with prediabetes and overweight or obesity in a 10-week randomized trial. This narrow metabolic result does not demonstrate lifespan extension or establish equivalence of other preparations.
The catalog does not record a single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule.
Half-life on file: no single hour value. No verified human estimate for this exact preparation is supplied. A half-life is not a treatment schedule. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.
This card has no units chart until a milligram size is listed.
People using PepBear often log: Exact product identity, formulation, dated label and any clinician-directed observations. Record symptoms and changes alongside other medicines, sleep and activity; observations do not establish causation.
not established. No approval for this exact marketed preparation or claimed wellness indication is established in this source set.
The calculator turns numbers you type into U-100 units. Trial or label amounts stay as cited facts.
Discuss the evidence and unresolved identity or safety questions with a licensed clinician. This entry provides no treatment instructions. Not medical advice. PepBear does not pick a dose, a cycle, or a seller.